ALFA Finder| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 0.1 | 0.1 | 0.2 |
| Total income | 1.2 | 0.8 | 1.7 |
| Net profit | 0.1 | -0.5 | 0.4 |
| Operating margin | 8.3% | -62.5% | 23.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -75.00% |
|---|
BSE results filing, BSE: 542918. Figures extracted from the filing.
Gian Life Care Ltd: key numbers
- Share price
- ₹4.29
- Market cap
- ₹4.44 Cr
- Revenue (annual)
- ₹6.63 Cr
- Net profit (annual)
- ₹-0.04 Cr
- P/E (TTM)
- -4.7×Sector 55.1×
- Promoter holding
- 30.17%-1.92% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gian Life Care Ltd
All →Garlon Polyfab Industries Board Meeting Date
Garlon Polyfab Industries Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited standalone financial results for June 2026.
Garlon Polyfab Industries Board Meeting Date
Garlon Polyfab Industries scheduled a board meeting for May 30, 2026, to approve audited financial results. The trading window remains closed until June 1, 2026.
Gian Life Care Q2 FY26 Results: Net Loss of ₹0.5 Cr
Gian Life Care Ltd reported a net loss of ₹0.5 Cr for Q2 FY26.
- Key figure
- Net loss ₹0.5 Cr